Observational studyHIV medicine2025

Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics.

Eisuke Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.